The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Biologics Contract Development and Manufacturing Organization(CDMO) Market 2024 by Company, Regions, Type and Application, Forecast to 2028
Synopsis
The Biologics Contract Development and Manufacturing Organization(CDMO) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Biologics Contract Development and Manufacturing Organization(CDMO) market size is estimated to be worth US$ 11640 million in 2021 and is forecast to a readjusted size of USD 23370 million by 2028 with a CAGR of 10.5% during review period. Big Pharma accounting for % of the Biologics Contract Development and Manufacturing Organization(CDMO) global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Biologics Contract Development Services segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Biologics Contract Development and Manufacturing Organization(CDMO) include Lonza, Hansen, Boehringer Ingelheim BioXcellence, Thermo Fisher Scientific, and Samsung BioLogics, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Biologics Contract Development and Manufacturing Organization(CDMO) market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Biologics Contract Development Services
Biologics Contract Manufacturing Services
Market segment by Application, can be divided into
Big Pharma
Small Pharma
Generic Pharma
Other
Market segment by players, this report covers
Lonza
Hansen
Boehringer Ingelheim BioXcellence
Thermo Fisher Scientific
Samsung BioLogics
AGC Biologics
Catalent
Wuxi Biologics
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Biologics Contract Development and Manufacturing Organization(CDMO) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Biologics Contract Development and Manufacturing Organization(CDMO), with revenue, gross margin and global market share of Biologics Contract Development and Manufacturing Organization(CDMO) from 2019 to 2022.
Chapter 3, the Biologics Contract Development and Manufacturing Organization(CDMO) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Biologics Contract Development and Manufacturing Organization(CDMO) market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Biologics Contract Development and Manufacturing Organization(CDMO) research findings and conclusion, appendix and data source.
Geographical Area
Global
The Biologics Contract Development and Manufacturing Organization(CDMO) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Biologics Contract Development and Manufacturing Organization(CDMO) market size is estimated to be worth US$ 11640 million in 2021 and is forecast to a readjusted size of USD 23370 million by 2028 with a CAGR of 10.5% during review period. Big Pharma accounting for % of the Biologics Contract Development and Manufacturing Organization(CDMO) global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Biologics Contract Development Services segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Biologics Contract Development and Manufacturing Organization(CDMO) include Lonza, Hansen, Boehringer Ingelheim BioXcellence, Thermo Fisher Scientific, and Samsung BioLogics, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Biologics Contract Development and Manufacturing Organization(CDMO) market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Biologics Contract Development Services
Biologics Contract Manufacturing Services
Market segment by Application, can be divided into
Big Pharma
Small Pharma
Generic Pharma
Other
Market segment by players, this report covers
Lonza
Hansen
Boehringer Ingelheim BioXcellence
Thermo Fisher Scientific
Samsung BioLogics
AGC Biologics
Catalent
Wuxi Biologics
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Biologics Contract Development and Manufacturing Organization(CDMO) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Biologics Contract Development and Manufacturing Organization(CDMO), with revenue, gross margin and global market share of Biologics Contract Development and Manufacturing Organization(CDMO) from 2019 to 2022.
Chapter 3, the Biologics Contract Development and Manufacturing Organization(CDMO) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Biologics Contract Development and Manufacturing Organization(CDMO) market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Biologics Contract Development and Manufacturing Organization(CDMO) research findings and conclusion, appendix and data source.
Geographical Area
Global
Index1 Market Overview
1.1 Product Overview and Scope of Biologics Contract Development and Manufacturing Organization(CDMO)
1.2 Classification of Biologics Contract Development and Manufacturing Organization(CDMO) by Type
1.2.1 Overview: Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Biologics Contract Development and Manufacturing Organization(CDMO) Revenue Market Share by Type in 2021
1.2.3 Biologics Contract Development Services
1.2.4 Biologics Contract Manufacturing Services
1.3 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market by Application
1.3.1 Overview: Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Big Pharma
1.3.3 Small Pharma
1.3.4 Generic Pharma
1.3.5 Other
1.4 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size & Forecast
1.5 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size and Forecast by Region
1.5.1 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Region, (2017-2022)
1.5.3 North America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size and Prospect (2017-2028)
1.5.4 Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Market Size and Prospect (2017-2028)
1.5.6 South America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Biologics Contract Development and Manufacturing Organization(CDMO) Market Drivers
1.6.2 Biologics Contract Development and Manufacturing Organization(CDMO) Market Restraints
1.6.3 Biologics Contract Development and Manufacturing Organization(CDMO) Trends Analysis
2 Company Profiles
2.1 Lonza
2.1.1 Lonza Details
2.1.2 Lonza Major Business
2.1.3 Lonza Biologics Contract Development and Manufacturing Organization(CDMO) Product and Solutions
2.1.4 Lonza Biologics Contract Development and Manufacturing Organization(CDMO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Lonza Recent Developments and Future Plans
2.2 Hansen
2.2.1 Hansen Details
2.2.2 Hansen Major Business
2.2.3 Hansen Biologics Contract Development and Manufacturing Organization(CDMO) Product and Solutions
2.2.4 Hansen Biologics Contract Development and Manufacturing Organization(CDMO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Hansen Recent Developments and Future Plans
2.3 Boehringer Ingelheim BioXcellence
2.3.1 Boehringer Ingelheim BioXcellence Details
2.3.2 Boehringer Ingelheim BioXcellence Major Business
2.3.3 Boehringer Ingelheim BioXcellence Biologics Contract Development and Manufacturing Organization(CDMO) Product and Solutions
2.3.4 Boehringer Ingelheim BioXcellence Biologics Contract Development and Manufacturing Organization(CDMO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Boehringer Ingelheim BioXcellence Recent Developments and Future Plans
2.4 Thermo Fisher Scientific
2.4.1 Thermo Fisher Scientific Details
2.4.2 Thermo Fisher Scientific Major Business
2.4.3 Thermo Fisher Scientific Biologics Contract Development and Manufacturing Organization(CDMO) Product and Solutions
2.4.4 Thermo Fisher Scientific Biologics Contract Development and Manufacturing Organization(CDMO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.5 Samsung BioLogics
2.5.1 Samsung BioLogics Details
2.5.2 Samsung BioLogics Major Business
2.5.3 Samsung BioLogics Biologics Contract Development and Manufacturing Organization(CDMO) Product and Solutions
2.5.4 Samsung BioLogics Biologics Contract Development and Manufacturing Organization(CDMO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Samsung BioLogics Recent Developments and Future Plans
2.6 AGC Biologics
2.6.1 AGC Biologics Details
2.6.2 AGC Biologics Major Business
2.6.3 AGC Biologics Biologics Contract Development and Manufacturing Organization(CDMO) Product and Solutions
2.6.4 AGC Biologics Biologics Contract Development and Manufacturing Organization(CDMO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 AGC Biologics Recent Developments and Future Plans
2.7 Catalent
2.7.1 Catalent Details
2.7.2 Catalent Major Business
2.7.3 Catalent Biologics Contract Development and Manufacturing Organization(CDMO) Product and Solutions
2.7.4 Catalent Biologics Contract Development and Manufacturing Organization(CDMO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Catalent Recent Developments and Future Plans
2.8 Wuxi Biologics
2.8.1 Wuxi Biologics Details
2.8.2 Wuxi Biologics Major Business
2.8.3 Wuxi Biologics Biologics Contract Development and Manufacturing Organization(CDMO) Product and Solutions
2.8.4 Wuxi Biologics Biologics Contract Development and Manufacturing Organization(CDMO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Wuxi Biologics Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Biologics Contract Development and Manufacturing Organization(CDMO) Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Biologics Contract Development and Manufacturing Organization(CDMO) Players Market Share in 2021
3.2.2 Top 10 Biologics Contract Development and Manufacturing Organization(CDMO) Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Biologics Contract Development and Manufacturing Organization(CDMO) Players Head Office, Products and Services Provided
3.4 Biologics Contract Development and Manufacturing Organization(CDMO) Mergers & Acquisitions
3.5 Biologics Contract Development and Manufacturing Organization(CDMO) New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Biologics Contract Development and Manufacturing Organization(CDMO) Revenue and Market Share by Type (2017-2022)
4.2 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Biologics Contract Development and Manufacturing Organization(CDMO) Revenue Market Share by Application (2017-2022)
5.2 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Biologics Contract Development and Manufacturing Organization(CDMO) Revenue by Type (2017-2028)
6.2 North America Biologics Contract Development and Manufacturing Organization(CDMO) Revenue by Application (2017-2028)
6.3 North America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Country
6.3.1 North America Biologics Contract Development and Manufacturing Organization(CDMO) Revenue by Country (2017-2028)
6.3.2 United States Biologics Contract Development and Manufacturing Organization(CDMO) Market Size and Forecast (2017-2028)
6.3.3 Canada Biologics Contract Development and Manufacturing Organization(CDMO) Market Size and Forecast (2017-2028)
6.3.4 Mexico Biologics Contract Development and Manufacturing Organization(CDMO) Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Biologics Contract Development and Manufacturing Organization(CDMO) Revenue by Type (2017-2028)
7.2 Europe Biologics Contract Development and Manufacturing Organization(CDMO) Revenue by Application (2017-2028)
7.3 Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Country
7.3.1 Europe Biologics Contract Development and Manufacturing Organization(CDMO) Revenue by Country (2017-2028)
7.3.2 Germany Biologics Contract Development and Manufacturing Organization(CDMO) Market Size and Forecast (2017-2028)
7.3.3 France Biologics Contract Development and Manufacturing Organization(CDMO) Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Biologics Contract Development and Manufacturing Organization(CDMO) Market Size and Forecast (2017-2028)
7.3.5 Russia Biologics Contract Development and Manufacturing Organization(CDMO) Market Size and Forecast (2017-2028)
7.3.6 Italy Biologics Contract Development and Manufacturing Organization(CDMO) Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Revenue by Type (2017-2028)
8.2 Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Revenue by Application (2017-2028)
8.3 Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Region
8.3.1 Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Revenue by Region (2017-2028)
8.3.2 China Biologics Contract Development and Manufacturing Organization(CDMO) Market Size and Forecast (2017-2028)
8.3.3 Japan Biologics Contract Development and Manufacturing Organization(CDMO) Market Size and Forecast (2017-2028)
8.3.4 South Korea Biologics Contract Development and Manufacturing Organization(CDMO) Market Size and Forecast (2017-2028)
8.3.5 India Biologics Contract Development and Manufacturing Organization(CDMO) Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Biologics Contract Development and Manufacturing Organization(CDMO) Market Size and Forecast (2017-2028)
8.3.7 Australia Biologics Contract Development and Manufacturing Organization(CDMO) Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Biologics Contract Development and Manufacturing Organization(CDMO) Revenue by Type (2017-2028)
9.2 South America Biologics Contract Development and Manufacturing Organization(CDMO) Revenue by Application (2017-2028)
9.3 South America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Country
9.3.1 South America Biologics Contract Development and Manufacturing Organization(CDMO) Revenue by Country (2017-2028)
9.3.2 Brazil Biologics Contract Development and Manufacturing Organization(CDMO) Market Size and Forecast (2017-2028)
9.3.3 Argentina Biologics Contract Development and Manufacturing Organization(CDMO) Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Revenue by Type (2017-2028)
10.2 Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Revenue by Application (2017-2028)
10.3 Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Country
10.3.1 Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Revenue by Country (2017-2028)
10.3.2 Turkey Biologics Contract Development and Manufacturing Organization(CDMO) Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Biologics Contract Development and Manufacturing Organization(CDMO) Market Size and Forecast (2017-2028)
10.3.4 UAE Biologics Contract Development and Manufacturing Organization(CDMO) Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of TablesList of Tables
Table 1. Global Biologics Contract Development and Manufacturing Organization(CDMO) Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Biologics Contract Development and Manufacturing Organization(CDMO) Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Biologics Contract Development and Manufacturing Organization(CDMO) Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Biologics Contract Development and Manufacturing Organization(CDMO) Revenue (USD Million) by Region (2017-2022)
Table 5. Global Biologics Contract Development and Manufacturing Organization(CDMO) Revenue Market Share by Region (2023-2028)
Table 6. Lonza Corporate Information, Head Office, and Major Competitors
Table 7. Lonza Major Business
Table 8. Lonza Biologics Contract Development and Manufacturing Organization(CDMO) Product and Solutions
Table 9. Lonza Biologics Contract Development and Manufacturing Organization(CDMO) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Hansen Corporate Information, Head Office, and Major Competitors
Table 11. Hansen Major Business
Table 12. Hansen Biologics Contract Development and Manufacturing Organization(CDMO) Product and Solutions
Table 13. Hansen Biologics Contract Development and Manufacturing Organization(CDMO) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Boehringer Ingelheim BioXcellence Corporate Information, Head Office, and Major Competitors
Table 15. Boehringer Ingelheim BioXcellence Major Business
Table 16. Boehringer Ingelheim BioXcellence Biologics Contract Development and Manufacturing Organization(CDMO) Product and Solutions
Table 17. Boehringer Ingelheim BioXcellence Biologics Contract Development and Manufacturing Organization(CDMO) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 19. Thermo Fisher Scientific Major Business
Table 20. Thermo Fisher Scientific Biologics Contract Development and Manufacturing Organization(CDMO) Product and Solutions
Table 21. Thermo Fisher Scientific Biologics Contract Development and Manufacturing Organization(CDMO) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Samsung BioLogics Corporate Information, Head Office, and Major Competitors
Table 23. Samsung BioLogics Major Business
Table 24. Samsung BioLogics Biologics Contract Development and Manufacturing Organization(CDMO) Product and Solutions
Table 25. Samsung BioLogics Biologics Contract Development and Manufacturing Organization(CDMO) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. AGC Biologics Corporate Information, Head Office, and Major Competitors
Table 27. AGC Biologics Major Business
Table 28. AGC Biologics Biologics Contract Development and Manufacturing Organization(CDMO) Product and Solutions
Table 29. AGC Biologics Biologics Contract Development and Manufacturing Organization(CDMO) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Catalent Corporate Information, Head Office, and Major Competitors
Table 31. Catalent Major Business
Table 32. Catalent Biologics Contract Development and Manufacturing Organization(CDMO) Product and Solutions
Table 33. Catalent Biologics Contract Development and Manufacturing Organization(CDMO) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Wuxi Biologics Corporate Information, Head Office, and Major Competitors
Table 35. Wuxi Biologics Major Business
Table 36. Wuxi Biologics Biologics Contract Development and Manufacturing Organization(CDMO) Product and Solutions
Table 37. Wuxi Biologics Biologics Contract Development and Manufacturing Organization(CDMO) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Global Biologics Contract Development and Manufacturing Organization(CDMO) Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 39. Global Biologics Contract Development and Manufacturing Organization(CDMO) Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 40. Breakdown of Biologics Contract Development and Manufacturing Organization(CDMO) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 41. Biologics Contract Development and Manufacturing Organization(CDMO) Players Head Office, Products and Services Provided
Table 42. Biologics Contract Development and Manufacturing Organization(CDMO) Mergers & Acquisitions in the Past Five Years
Table 43. Biologics Contract Development and Manufacturing Organization(CDMO) New Entrants and Expansion Plans
Table 44. Global Biologics Contract Development and Manufacturing Organization(CDMO) Revenue (USD Million) by Type (2017-2022)
Table 45. Global Biologics Contract Development and Manufacturing Organization(CDMO) Revenue Share by Type (2017-2022)
Table 46. Global Biologics Contract Development and Manufacturing Organization(CDMO) Revenue Forecast by Type (2023-2028)
Table 47. Global Biologics Contract Development and Manufacturing Organization(CDMO) Revenue by Application (2017-2022)
Table 48. Global Biologics Contract Development and Manufacturing Organization(CDMO) Revenue Forecast by Application (2023-2028)
Table 49. North America Biologics Contract Development and Manufacturing Organization(CDMO) Revenue by Type (2017-2022) & (USD Million)
Table 50. North America Biologics Contract Development and Manufacturing Organization(CDMO) Revenue by Type (2023-2028) & (USD Million)
Table 51. North America Biologics Contract Development and Manufacturing Organization(CDMO) Revenue by Application (2017-2022) & (USD Million)
Table 52. North America Biologics Contract Development and Manufacturing Organization(CDMO) Revenue by Application (2023-2028) & (USD Million)
Table 53. North America Biologics Contract Development and Manufacturing Organization(CDMO) Revenue by Country (2017-2022) & (USD Million)
Table 54. North America Biologics Contract Development and Manufacturing Organization(CDMO) Revenue by Country (2023-2028) & (USD Million)
Table 55. Europe Biologics Contract Development and Manufacturing Organization(CDMO) Revenue by Type (2017-2022) & (USD Million)
Table 56. Europe Biologics Contract Development and Manufacturing Organization(CDMO) Revenue by Type (2023-2028) & (USD Million)
Table 57. Europe Biologics Contract Development and Manufacturing Organization(CDMO) Revenue by Application (2017-2022) & (USD Million)
Table 58. Europe Biologics Contract Development and Manufacturing Organization(CDMO) Revenue by Application (2023-2028) & (USD Million)
Table 59. Europe Biologics Contract Development and Manufacturing Organization(CDMO) Revenue by Country (2017-2022) & (USD Million)
Table 60. Europe Biologics Contract Development and Manufacturing Organization(CDMO) Revenue by Country (2023-2028) & (USD Million)
Table 61. Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Revenue by Type (2017-2022) & (USD Million)
Table 62. Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Revenue by Type (2023-2028) & (USD Million)
Table 63. Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Revenue by Application (2017-2022) & (USD Million)
Table 64. Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Revenue by Application (2023-2028) & (USD Million)
Table 65. Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Revenue by Region (2017-2022) & (USD Million)
Table 66. Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Revenue by Region (2023-2028) & (USD Million)
Table 67. South America Biologics Contract Development and Manufacturing Organization(CDMO) Revenue by Type (2017-2022) & (USD Million)
Table 68. South America Biologics Contract Development and Manufacturing Organization(CDMO) Revenue by Type (2023-2028) & (USD Million)
Table 69. South America Biologics Contract Development and Manufacturing Organization(CDMO) Revenue by Application (2017-2022) & (USD Million)
Table 70. South America Biologics Contract Development and Manufacturing Organization(CDMO) Revenue by Application (2023-2028) & (USD Million)
Table 71. South America Biologics Contract Development and Manufacturing Organization(CDMO) Revenue by Country (2017-2022) & (USD Million)
Table 72. South America Biologics Contract Development and Manufacturing Organization(CDMO) Revenue by Country (2023-2028) & (USD Million)
Table 73. Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Revenue by Type (2017-2022) & (USD Million)
Table 74. Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Revenue by Type (2023-2028) & (USD Million)
Table 75. Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Revenue by Application (2017-2022) & (USD Million)
Table 76. Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Revenue by Application (2023-2028) & (USD Million)
Table 77. Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Revenue by Country (2017-2022) & (USD Million)
Table 78. Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Biologics Contract Development and Manufacturing Organization(CDMO) Picture
Figure 2. Global Biologics Contract Development and Manufacturing Organization(CDMO) Revenue Market Share by Type in 2021
Figure 3. Biologics Contract Development Services
Figure 4. Biologics Contract Manufacturing Services
Figure 5. Biologics Contract Development and Manufacturing Organization(CDMO) Revenue Market Share by Application in 2021
Figure 6. Big Pharma Picture
Figure 7. Small Pharma Picture
Figure 8. Generic Pharma Picture
Figure 9. Other Picture
Figure 10. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 11. Global Biologics Contract Development and Manufacturing Organization(CDMO) Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Biologics Contract Development and Manufacturing Organization(CDMO) Revenue Market Share by Region (2017-2028)
Figure 13. Global Biologics Contract Development and Manufacturing Organization(CDMO) Revenue Market Share by Region in 2021
Figure 14. North America Biologics Contract Development and Manufacturing Organization(CDMO) Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. Europe Biologics Contract Development and Manufacturing Organization(CDMO) Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. South America Biologics Contract Development and Manufacturing Organization(CDMO) Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Middle East and Africa Biologics Contract Development and Manufacturing Organization(CDMO) Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Biologics Contract Development and Manufacturing Organization(CDMO) Market Drivers
Figure 20. Biologics Contract Development and Manufacturing Organization(CDMO) Market Restraints
Figure 21. Biologics Contract Development and Manufacturing Organization(CDMO) Market Trends
Figure 22. Lonza Recent Developments and Future Plans
Figure 23. Hansen Recent Developments and Future Plans
Figure 24. Boehringer Ingelheim BioXcellence Recent Developments and Future Plans
Figure 25. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 26. Samsung BioLogics Recent Developments and Future Plans
Figure 27. AGC Biologics Recent Developments and Future Plans
Figure 28. Catalent Recent Developments and Future Plans
Figure 29. Wuxi Biologics Recent Developments and Future Plans
Figure 30. Global Biologics Contract Development and Manufacturing Organization(CDMO) Revenue Share by Players in 2021
Figure 31. Biologics Contract Development and Manufacturing Organization(CDMO) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 32. Global Top 3 Players Biologics Contract Development and Manufacturing Organization(CDMO) Revenue Market Share in 2021
Figure 33. Global Top 10 Players Biologics Contract Development and Manufacturing Organization(CDMO) Revenue Market Share in 2021
Figure 34. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 35. Global Biologics Contract Development and Manufacturing Organization(CDMO) Revenue Share by Type in 2021
Figure 36. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Share Forecast by Type (2023-2028)
Figure 37. Global Biologics Contract Development and Manufacturing Organization(CDMO) Revenue Share by Application in 2021
Figure 38. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Share Forecast by Application (2023-2028)
Figure 39. North America Biologics Contract Development and Manufacturing Organization(CDMO) Sales Market Share by Type (2017-2028)
Figure 40. North America Biologics Contract Development and Manufacturing Organization(CDMO) Sales Market Share by Application (2017-2028)
Figure 41. North America Biologics Contract Development and Manufacturing Organization(CDMO) Revenue Market Share by Country (2017-2028)
Figure 42. United States Biologics Contract Development and Manufacturing Organization(CDMO) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Biologics Contract Development and Manufacturing Organization(CDMO) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Biologics Contract Development and Manufacturing Organization(CDMO) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Biologics Contract Development and Manufacturing Organization(CDMO) Sales Market Share by Type (2017-2028)
Figure 46. Europe Biologics Contract Development and Manufacturing Organization(CDMO) Sales Market Share by Application (2017-2028)
Figure 47. Europe Biologics Contract Development and Manufacturing Organization(CDMO) Revenue Market Share by Country (2017-2028)
Figure 48. Germany Biologics Contract Development and Manufacturing Organization(CDMO) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Biologics Contract Development and Manufacturing Organization(CDMO) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Biologics Contract Development and Manufacturing Organization(CDMO) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Biologics Contract Development and Manufacturing Organization(CDMO) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Biologics Contract Development and Manufacturing Organization(CDMO) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Sales Market Share by Type (2017-2028)
Figure 54. Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Revenue Market Share by Region (2017-2028)
Figure 56. China Biologics Contract Development and Manufacturing Organization(CDMO) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Biologics Contract Development and Manufacturing Organization(CDMO) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. South Korea Biologics Contract Development and Manufacturing Organization(CDMO) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Biologics Contract Development and Manufacturing Organization(CDMO) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Biologics Contract Development and Manufacturing Organization(CDMO) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Biologics Contract Development and Manufacturing Organization(CDMO) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Biologics Contract Development and Manufacturing Organization(CDMO) Sales Market Share by Type (2017-2028)
Figure 63. South America Biologics Contract Development and Manufacturing Organization(CDMO) Sales Market Share by Application (2017-2028)
Figure 64. South America Biologics Contract Development and Manufacturing Organization(CDMO) Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Biologics Contract Development and Manufacturing Organization(CDMO) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Biologics Contract Development and Manufacturing Organization(CDMO) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East and Africa Biologics Contract Development and Manufacturing Organization(CDMO) Sales Market Share by Type (2017-2028)
Figure 68. Middle East and Africa Biologics Contract Development and Manufacturing Organization(CDMO) Sales Market Share by Application (2017-2028)
Figure 69. Middle East and Africa Biologics Contract Development and Manufacturing Organization(CDMO) Revenue Market Share by Country (2017-2028)
Figure 70. Turkey Biologics Contract Development and Manufacturing Organization(CDMO) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Saudi Arabia Biologics Contract Development and Manufacturing Organization(CDMO) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. UAE Biologics Contract Development and Manufacturing Organization(CDMO) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Methodology
Figure 74. Research Process and Data Source
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
